Medmira (47M) Stock Statistics & Valuation Metrics
Total Valuation
Medmira has a market cap or net worth of EUR 23.76M. The enterprise value is EUR 55.31T.
- Market Cap
- EUR 23.76M
- Enterprise Value
- EUR 55.31T
Share Statistics
Medmira has 701,730,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 701,730,600
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
Medmira’s return on equity (ROE) is 0.20 and return on invested capital (ROIC) is 30.28%.
- Return on Equity (ROE)
- 0.20
- Return on Assets (ROA)
- -1.23
- Return on Invested Capital (ROIC)
- 30.28%
- Return on Capital Employed (ROCE)
- 0.20
- Revenue Per Employee
- 4,625.173
- Profits Per Employee
- -87.01K
- Employee Count
- 52
- Asset Turnover
- 0.07
- Inventory Turnover
- 5.97
Valuation Ratios
The current PE Ratio of Medmira is -11.36. Medmira’s PEG ratio is -0.25.
- PE Ratio
- -11.36
- PS Ratio
- 94.68
- PB Ratio
- -1.42
- Price to FCF
- -29.48
- Price to Operating Cash Flow
- -29.31
- PEG Ratio
- -0.25
Income Statement
In the last 12 months, Medmira had revenue of 240.51K and earned -4.52M in profits. Earnings per share was -0.01.
- Revenue
- 240.51K
- Gross Profit
- -990.25K
- Operating Income
- -3.59M
- Pretax Income
- -4.52M
- Net Income
- -4.52M
- EBITDA
- -3.13M
- Earnings Per Share (EPS)
- -0.01
Cash Flow
In the last 12 months, operating cash flow was -1.19M and capital expenditures 0, giving a free cash flow of -1.19M billion.
- Operating Cash Flow
- -1.19M
- Free Cash Flow
- -1.19M
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Medmira pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -3.39%
- Earnings Yield
- -8.59%
Stock Price Statistics
- Beta
- 0.01
- 52-Week Price Change
- -43.59%
- 50-Day Moving Average
- 0.03
- 200-Day Moving Average
- 0.03
- Relative Strength Index (RSI)
- 40.51
- Average Volume (3m)
- 5,725
Important Dates
Medmira upcoming earnings date is Dec 02, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Jun 30, 2026
- Next Earnings Date
- Dec 02, 2026
- Ex-Dividend Date
- ―
Financial Position
Medmira as a current ratio of 0.07, with Debt / Equity ratio of -47.45%
- Current Ratio
- 0.07
- Quick Ratio
- 0.06
- Debt to Market Cap
- 0.15
- Net Debt to EBITDA
- -3.42
- Interest Coverage Ratio
- -3.33
Taxes
In the past 12 months, Medmira has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Medmira EV to EBITDA ratio is -29.96, with an EV/FCF ratio of -44.11.
- EV to Sales
- 141.69
- EV to EBITDA
- -29.96
- EV to Free Cash Flow
- -44.11
- EV to Operating Cash Flow
- -44.11
Balance Sheet
Medmira has EUR 0.00 in cash and marketable securities with EUR 17.42M in debt, giving a net cash position of -EUR 17.42M billion.
- Cash & Marketable Securities
- EUR 0.00
- Total Debt
- EUR 17.42M
- Net Cash
- -EUR 17.42M
- Net Cash Per Share
- -EUR 0.02
- Tangible Book Value Per Share
- -EUR 0.04
Margins
Gross margin is -448.07%, with operating margin of -473.40%, and net profit margin of -808.18%.
- Gross Margin
- -448.07%
- Operating Margin
- -473.40%
- Pretax Margin
- -808.18%
- Net Profit Margin
- -808.18%
- EBITDA Margin
- -473.01%
- EBIT Margin
- -554.58%
Analyst Forecast
The average price target for Medmira is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 36.43%
- EPS Growth Forecast
- 38.64%
